After a year-long voluntary moratorium to discuss regulations and safety measures, scientists are set to resume controversial H5N1 research.
Advertisement
The Scientist
Most Recent
Tumor cells rapidly divide by usurping a metabolic trick from normal cell development.
Long-term, life, and disability insurers may still be able to deny coverage to patients with a genetic disease, under current nondiscrimination legislation.
Male scientists commit research misconduct more often than their female peers, and senior researchers are more likely to engage in fraud than trainees.
The US Food and Drug Administration approves the first flu vaccine made from recombinant proteins rather than a weakened virus.
Fecal transplants outcompeted traditional antibiotics at curing a deadly intestinal infection.
Scientists use virus-free gene therapy on patient-derived stem cells to repair spinal muscular atrophy in mice.
Academics get paid handsome fees to consult with the financial industry, but run the risk of revealing confidential information that leads to illicit gains.
Researchers and biotech companies are bringing a universal flu vaccine closer to reality.
Resource-limited countries are in desperate need of better diagnostic tests for life-threatening illnesses.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
